Experimental models confirm T-cell and B-cell involvement in AMD pathology [175], supported by single-cell RNA sequencing revealing CD16+ monocyte signatures associated with anti-VEGF treatment burden [176]. The gene discussed is VEGFA; the disease is age-related macular degeneration.